Medium materiality6/10
Teva price target raised to $42 from $40 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
TEVA received an analyst target update from Barclays.
- Barclays raises TEVA target to $42; current price $36.48.
Key facts
- 01
Target: $42
- 02
Posted price: $36.48
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.